Atypical Hemolytic Uremic Syndrome (aHUS) Unknown Status Phase 3 Trials for Narsoplimab (DB16418)

Back to Atypical Hemolytic Uremic Syndrome (aHUS)

Also known as: Atypical Hemolytic Uraemic Syndrome / Atypical Hemolytic-Uremic Syndrome / Atypical Hemolytic Uremic Syndrome / Hemolytic-Uremic Syndrome, Atypical / Hemolytic Uremic Syndrome, Atypical / Atypical hemolytic uremic syndrome (disorder) / Atypical haemolytic uraemic syndrome / AHUS

IndicationStatusPhase
DBCOND0061539 (Atypical Hemolytic Uremic Syndrome (aHUS))Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03205995Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic SyndromeTreatment